News

Many cases of cutaneous mastocytosis remain confined to the skin, but some may indicate a risk for systemic mastocytosis (SM).

Avapritinib treatment improves survival outcomes and symptom management in patients with SM, its maker reported.

Physicians continue to raise standards in SM diagnosis and care, allowing patients with advanced SM to achieve better long-term outcomes.

A hematologist detailed several cases of SM that highlighted the need for diligence in diagnosing and managing treatment of ISM.

Patients with SM and venom allergies may face increased risks during immunotherapy if they have a particular genetic variant.

A recent case report illustrated the need for thorough care to prevent adverse postoperative outcomes in patients with SM.

A young woman with SM was misdiagnosed after repeated episodes of altered consciousness following insect stings.

A case study illustrated the difficulty of diagnosing systemic mastocytosis (SM), particularly in children.

Patients with advanced mastocytosis showed significantly higher sclerostin concentrations, especially in those with bone disease.

Patients with indolent systemic mastocytosis appear to have a quality of life comparable to that of patients with lymphoma and leukemia